Nuveen Asset Management’s BioXcel Therapeutics BTAI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,808
| Closed | -$43.7K | – | 3281 |
|
|
2023
Q4 | $43.7K | Hold |
14,808
| – | – | ﹤0.01% | 3306 |
|
|
2023
Q3 | $37.5K | Hold |
14,808
| – | – | ﹤0.01% | 3163 |
|
|
2023
Q2 | $98.6K | Sell |
14,808
-46,532
| -76% | -$310K | ﹤0.01% | 3156 |
|
|
2023
Q1 | $1.15M | Sell |
61,340
-143,067
| -70% | -$2.67M | ﹤0.01% | 2560 |
|
|
2022
Q4 | $4.39M | Sell |
204,407
-13,217
| -6% | -$284K | ﹤0.01% | 1988 |
|
|
2022
Q3 | $2.57M | Buy |
217,624
+106,314
| +96% | +$1.26M | ﹤0.01% | 2269 |
|
|
2022
Q2 | $1.47M | Buy |
111,310
+54,304
| +95% | +$717K | ﹤0.01% | 2604 |
|
|
2022
Q1 | $958K | Sell |
57,006
-3,215
| -5% | -$54K | ﹤0.01% | 2830 |
|
|
2021
Q4 | $1.22M | Buy |
60,221
+13,694
| +29% | +$278K | ﹤0.01% | 2784 |
|
|
2021
Q3 | $1.43M | Sell |
46,527
-9,275
| -17% | -$285K | ﹤0.01% | 2827 |
|
|
2021
Q2 | $1.62M | Buy |
55,802
+2,308
| +4% | +$67.1K | ﹤0.01% | 2803 |
|
|
2021
Q1 | $2.31M | Sell |
53,494
-1,576
| -3% | -$68K | ﹤0.01% | 2547 |
|
|
2020
Q4 | $2.55M | Sell |
55,070
-39,025
| -41% | -$1.8M | ﹤0.01% | 2393 |
|
|
2020
Q3 | $4.08M | Sell |
94,095
-60,912
| -39% | -$2.64M | ﹤0.01% | 2030 |
|
|
2020
Q2 | $8.22M | Buy |
155,007
+861
| +0.6% | +$45.6K | ﹤0.01% | 1623 |
|
|
2020
Q1 | $3.45M | Buy |
154,146
+143,452
| +1,341% | +$3.21M | ﹤0.01% | 1909 |
|
|
2019
Q4 | $156K | Hold |
10,694
| – | – | ﹤0.01% | 3095 |
|
|
2019
Q3 | $75K | Hold |
10,694
| – | – | ﹤0.01% | 3180 |
|
|
2019
Q2 | $117K | Buy |
+10,694
| New | +$117K | ﹤0.01% | 3196 |
|